Global Brain Tumor Drugs Market Size Study & Forecast, by Therapy, by Indication, by Distribution Channel and Regional Analysis, 2023-2030

Description

List of Tables

Global Brain Tumor Drugs Market is valued at approximately USD 1.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2023-2030. Brain tumors are abnormal growths of cells that develop in the brain or nearby areas. Tumors that develop in the brain is the primary brain tumor and tumor that begin in other parts of the body is known as secondary or metastatic brain tumors. The size of the tumor varies from very small size to large size. The increasing prevalence of brain tumors is a major contributing factor to the growth of the market. However, the high cost of treatments hinder market expansion.

The rising prevalence of brain cancer due to changing lifestyle habits, rapid urbanization, and increasing rate of active smokers is driving the market growth. According to Globocan 2020 estimates, there were 308,102 new cases of brain cancer worldwide in 2021, resulting in 251,329 new deaths. According to the American Cancer Society, around 24,530 malignant brain or spinal cord tumors were diagnosed in 2021, with an additional 3,460 children under the age of 15 expected to be diagnosed with brain or CNS tumors this year. The European Society for Medical Oncology (ESMO) has adopted a neurosurgery protocol to slow down tumor progression and provide a longer survival time, according to a research study titled "Brain Tumor Management Amidst COVID-19 Pandemic" in August 2020. The growing concern for the disease and its treatment is driving the market, along with key players investing in research and development. Furthermore, increasing government initiatives to provide a conducive environment for drug approval and the rising number of pharmaceutical companies developing these drugs propel the market growth. However, the side effects associated with these drugs hinder market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain Tumor Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to proper reimbursement policies in the U.S. and the increasing launch of new drugs. Asia Pacific is expected to grow significantly over the forecast period, due to varying regulatory policies and rising awareness about cancer and its types. According to the Brain Tumor Research Organization, Australia has average rating of brain tumor care was the lowest of all cancers, with a score of 8.37 out of 10.

Major market player included in this report are:

Johnson & Johnson Services, Inc.
Bayer AG
F. Hoffmann-La Roche Ltd
Eisai Co. Ltd
Novartis AG
Merck & Co. Inc.
Amgen Inc.
AstraZeneca PLC,
Pfizer, Inc.
GlaxoSmithKline PLC

Recent Developments in the Market:

In November 2021, Pfizer Inc. acquired Trillium Therapeutics, a clinical-stage immuno-oncology company that focuses primarily on developing innovative therapies for the treatment of cancer.
In September 2022, F. Hoffmann-La Roche Ltd. acquired Good Therapeutics, to gain rights to Good Therapeutics' platform technology, which has applications in various fields such as autoimmune diseases, pain management, metabolic diseases, and cancer.

Global Brain Tumor Drugs Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Therapy, Indication, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

Targeted Therapy
Chemotherapy
Immunotherapy
Others

By Indication:

Pituitary
Meningioma
Glioma
Others

By Distribution Channel:

Hospital Pharmacy
Retail & Online Pharmacy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Brain Tumor Drugs Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Brain Tumor Drugs Market, by Therapy, 2020-2030 (USD Billion)
- 1.2.3. Brain Tumor Drugs Market, by Indication, 2020-2030 (USD Billion)
- 1.2.4. Brain Tumor Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Brain Tumor Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Brain Tumor Drugs Market Dynamics

3.1. Brain Tumor Drugs Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising prevalence of brain cancer cases
  - 3.1.1.2. Increasing awareness about the disease
  - 3.1.1.3. Strong R&D initiatives from strong players
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Therapy
  - 3.1.2.2. Side effects associated with the treatment
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing government initiatives
  - 3.1.3.2. Increasing rate of pharmaceutical companies that are developing these drugs

Chapter 4. Global Brain Tumor Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Brain Tumor Drugs Market, by Therapy

5.1. Market Snapshot
5.2. Global Brain Tumor Drugs Market by Therapy, Performance - Potential Analysis
5.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
5.4. Brain Tumor Drugs Market, Sub Segment Analysis
- 5.4.1. Targeted Therapy
- 5.4.2. Chemotherapy
- 5.4.3. Immunotherapy
- 5.4.4. Others

Chapter 6. Global Brain Tumor Drugs Market, by Indication

6.1. Market Snapshot
6.2. Global Brain Tumor Drugs Market by Indication, Performance - Potential Analysis
6.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. Brain Tumor Drugs Market, Sub Segment Analysis
- 6.4.1. Pituitary
- 6.4.2. Meningioma
- 6.4.3. Glioma
- 6.4.4. Others

Chapter 7. Global Brain Tumor Drugs Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Brain Tumor Drugs Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Brain Tumor Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Brain Tumor Drugs Market, Sub Segment Analysis
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail & Online Pharmacy

Chapter 8. Global Brain Tumor Drugs Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Brain Tumor Drugs Market, Regional Market Snapshot
8.4. North America Brain Tumor Drugs Market
- 8.4.1. U.S. Brain Tumor Drugs Market
  - 8.4.1.1. Therapy breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Brain Tumor Drugs Market
8.5. Europe Brain Tumor Drugs Market Snapshot
- 8.5.1. U.K. Brain Tumor Drugs Market
- 8.5.2. Germany Brain Tumor Drugs Market
- 8.5.3. France Brain Tumor Drugs Market
- 8.5.4. Spain Brain Tumor Drugs Market
- 8.5.5. Italy Brain Tumor Drugs Market
- 8.5.6. Rest of Europe Brain Tumor Drugs Market
8.6. Asia-Pacific Brain Tumor Drugs Market Snapshot
- 8.6.1. China Brain Tumor Drugs Market
- 8.6.2. India Brain Tumor Drugs Market
- 8.6.3. Japan Brain Tumor Drugs Market
- 8.6.4. Australia Brain Tumor Drugs Market
- 8.6.5. South Korea Brain Tumor Drugs Market
- 8.6.6. Rest of Asia Pacific Brain Tumor Drugs Market
8.7. Latin America Brain Tumor Drugs Market Snapshot
- 8.7.1. Brazil Brain Tumor Drugs Market
- 8.7.2. Mexico Brain Tumor Drugs Market
8.8. Middle East & Africa Brain Tumor Drugs Market
- 8.8.1. Saudi Arabia Brain Tumor Drugs Market
- 8.8.2. South Africa Brain Tumor Drugs Market
- 8.8.3. Rest of Middle East & Africa Brain Tumor Drugs Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Johnson & Johnson Services, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Bayer AG
- 9.3.3. F. Hoffmann-La Roche Ltd
- 9.3.4. Eisai Co. Ltd
- 9.3.5. Novartis AG
- 9.3.6. Merck & Co. Inc.
- 9.3.7. Amgen Inc.
- 9.3.8. AstraZeneca PLC,
- 9.3.9. Pfizer, Inc.
- 9.3.10. GlaxoSmithKline PLC

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Brain Tumor Drugs Market, report scope
TABLE 2. Global Brain Tumor Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Brain Tumor Drugs Market estimates & forecasts by Therapy 2020-2030 (USD Billion)
TABLE 4. Global Brain Tumor Drugs Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 5. Global Brain Tumor Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Brain Tumor Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Brain Tumor Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Brain Tumor Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Brain Tumor Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Brain Tumor Drugs Market
TABLE 71. List of primary sources, used in the study of global Brain Tumor Drugs Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Brain Tumor Drugs Market, research methodology
FIG 2. Global Brain Tumor Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Brain Tumor Drugs Market, key trends 2022
FIG 5. Global Brain Tumor Drugs Market, growth prospects 2023-2030
FIG 6. Global Brain Tumor Drugs Market, porters 5 force model
FIG 7. Global Brain Tumor Drugs Market, pest analysis
FIG 8. Global Brain Tumor Drugs Market, value chain analysis
FIG 9. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Brain Tumor Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Brain Tumor Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Brain Tumor Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Brain Tumor Drugs Market 2020 & 2030 (USD Billion)